Clinical monitoring of the antithrombotic treatment

Consequences of thrombosis, whether in the arterial or in the venous system, or in the left atrium in patients with atrial fibrillation, are the most common causes of death. Therefore, great attention is given to the prevention and treatment of thrombosis in the present. The aim of this review article is to summarize the current knowledge on the laboratory and clinical monitoring of the antithrombotic treatment.